000			02111 a2200601 4500
005			20250514042405.0
264		0	_c20020927
008			200209s 0 0 eng d
022			_a0340-7004
024	7		_a10.1007/s00262-002-0290-6 _2doi
040			_aNLM _beng _cNLM
100	1		_aZhao, Wenli
245	0	0	_aSuppression of in vivo tumorigenicity of rat hepatoma cell line KDH-8 cells by soluble TGF-beta receptor type II. _h[electronic resource]
260			_bCancer immunology, immunotherapy : CII _cSep 2002
300			_a381-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aApoptosis
650	0	4	_aCell Cycle
650	0	4	_aCell Line _xdrug effects
650	0	4	_aClone Cells _xpathology
650	0	4	_aFemale
650	0	4	_aInterleukin-2 _xbiosynthesis
650	0	4	_aLiver Neoplasms, Experimental _xpathology
650	0	4	_aLung
650	0	4	_aMacromolecular Substances
650	0	4	_aMink
650	0	4	_aNeoplasm Proteins _xantagonists & inhibitors
650	0	4	_aNeoplasm Transplantation
650	0	4	_aProtein Serine-Threonine Kinases
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aReceptor, Transforming Growth Factor-beta Type II
650	0	4	_aReceptors, Transforming Growth Factor beta _xgenetics
650	0	4	_aRecombinant Fusion Proteins _xphysiology
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aSolubility
650	0	4	_aSpleen _xcytology
650	0	4	_aTransfection
650	0	4	_aTransforming Growth Factor beta _xantagonists & inhibitors
650	0	4	_aTumor Cells, Cultured _xpathology
650	0	4	_aTumor Escape _xdrug effects
700	1		_aKobayashi, Masonobu
700	1		_aDing, Wei
700	1		_aYuan, Lan
700	1		_aSeth, Prem
700	1		_aCornain, Santoso
700	1		_aWang, Jingxin
700	1		_aOkada, Futoshi
700	1		_aHosokawa, Masuo
773	0		_tCancer immunology, immunotherapy : CII _gvol. 51 _gno. 7 _gp. 381-8
856	4	0	_uhttps://doi.org/10.1007/s00262-002-0290-6 _zAvailable from publisher's website
999			_c12074213 _d12074213